BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20823415)

  • 1. Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy.
    Xie Y; Minna JD
    J Clin Oncol; 2010 Oct; 28(29):4404-7. PubMed ID: 20823415
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer.
    Zhu CQ; Ding K; Strumpf D; Weir BA; Meyerson M; Pennell N; Thomas RK; Naoki K; Ladd-Acosta C; Liu N; Pintilie M; Der S; Seymour L; Jurisica I; Shepherd FA; Tsao MS
    J Clin Oncol; 2010 Oct; 28(29):4417-24. PubMed ID: 20823422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic signatures for predicting survival and adjuvant chemotherapy benefit in patients with non-small-cell lung cancer.
    Van Laar RK
    BMC Med Genomics; 2012 Jul; 5():30. PubMed ID: 22748043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.
    Winton T; Livingston R; Johnson D; Rigas J; Johnston M; Butts C; Cormier Y; Goss G; Inculet R; Vallieres E; Fry W; Bethune D; Ayoub J; Ding K; Seymour L; Graham B; Tsao MS; Gandara D; Kesler K; Demmy T; Shepherd F; ;
    N Engl J Med; 2005 Jun; 352(25):2589-97. PubMed ID: 15972865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study.
    Berghmans T; Ameye L; Willems L; Paesmans M; Mascaux C; Lafitte JJ; Meert AP; Scherpereel A; Cortot AB; Cstoth I; Dernies T; Toussaint L; Leclercq N; Sculier JP;
    Lung Cancer; 2013 Nov; 82(2):340-5. PubMed ID: 24007627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for non-small-cell lung cancer--the smoke clears.
    Pisters KM
    N Engl J Med; 2005 Jun; 352(25):2640-2. PubMed ID: 15972872
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer.
    Tsao MS; Sakurada A; Ding K; Aviel-Ronen S; Ludkovski O; Liu N; Le Maître A; Gandara D; Johnson DH; Rigas JR; Seymour L; Shepherd FA
    J Thorac Oncol; 2011 Jan; 6(1):139-47. PubMed ID: 21107284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.
    Arriagada R; Bergman B; Dunant A; Le Chevalier T; Pignon JP; Vansteenkiste J;
    N Engl J Med; 2004 Jan; 350(4):351-60. PubMed ID: 14736927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
    Buhl IK; Santoni-Rugiu E; Ravn J; Hansen A; Christensen IJ; Jensen T; Pratt B; Askaa J; Jensen PB; Knudsen S; Sørensen JB
    PLoS One; 2018; 13(3):e0194609. PubMed ID: 29566065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10.
    Sève P; Lai R; Ding K; Winton T; Butts C; Mackey J; Dumontet C; Dabbagh L; Aviel-Ronen S; Seymour L; Whitehead M; Tsao MS; Shepherd FA; Reiman T
    Clin Cancer Res; 2007 Feb; 13(3):994-9. PubMed ID: 17289895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Missing patient-reported outcome data in an adjuvant lung cancer study.
    Land SR
    J Clin Oncol; 2008 Nov; 26(31):5018-9. PubMed ID: 18809601
    [No Abstract]   [Full Text] [Related]  

  • 12. Early-stage lung cancer findings end a debate, put focus on next steps.
    McNeil C
    J Natl Cancer Inst; 2004 Jul; 96(14):1054-5. PubMed ID: 15265961
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting response to chemotherapy with early-stage lung cancer.
    Rosell R; Taron M; Massuti B; Mederos N; Magri I; Santarpia M; Sanchez JM
    Cancer J; 2011; 17(1):49-56. PubMed ID: 21263267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial.
    Douillard JY; Rosell R; De Lena M; Carpagnano F; Ramlau R; Gonzáles-Larriba JL; Grodzki T; Pereira JR; Le Groumellec A; Lorusso V; Clary C; Torres AJ; Dahabreh J; Souquet PJ; Astudillo J; Fournel P; Artal-Cortes A; Jassem J; Koubkova L; His P; Riggi M; Hurteloup P
    Lancet Oncol; 2006 Sep; 7(9):719-27. PubMed ID: 16945766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
    Malayeri R
    J Natl Cancer Inst; 2002 Aug; 94(15):1172; author reply 1172. PubMed ID: 12165643
    [No Abstract]   [Full Text] [Related]  

  • 16. Three-Year Follow-Up of a Randomized Phase II Trial on Refinement of Early-Stage NSCLC Adjuvant Chemotherapy with Cisplatin and Pemetrexed versus Cisplatin and Vinorelbine (the TREAT Study).
    Kreuter M; Vansteenkiste J; Fischer JR; Eberhardt WE; Zabeck H; Kollmeier J; Serke M; Frickhofen N; Reck M; Engel-Riedel W; Neumann S; Thomeer M; Schumann C; De Leyn P; Graeter T; Stamatis G; Griesinger F; Thomas M;
    J Thorac Oncol; 2016 Jan; 11(1):85-93. PubMed ID: 26762743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinorelbine (navelbine) in the treatment of non-small-cell lung cancer: recent developments in combination chemotherapy and radiotherapy.
    Gralla R; Harper P; Johnson S; Delgado FM
    Ann Oncol; 1999; 10 Suppl 5():S47-51. PubMed ID: 10582139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy in resected non-small cell lung cancer.
    Cangiano R
    Rays; 2004; 29(4):435-7. PubMed ID: 15852732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vinorelbine for non-small cell lung cancer].
    Seto T
    Nihon Rinsho; 2002 May; 60 Suppl 5():353-8. PubMed ID: 12101688
    [No Abstract]   [Full Text] [Related]  

  • 20. Post-operative treatment with cisplatin and vinorelbine in Chinese patients with non-small cell lung cancer: a clinical prospective analysis of 451 patients.
    Wang J; Liu F; Huang DX; Jiang B
    Asian Pac J Cancer Prev; 2012; 13(9):4505-10. PubMed ID: 23167369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.